chlorambucil has been researched along with Disseminated Intravascular Coagulation in 1 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
Disseminated Intravascular Coagulation: A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fresa, A | 1 |
| Autore, F | 1 |
| Innocenti, I | 1 |
| Piciocchi, A | 1 |
| Tomasso, A | 1 |
| Morelli, F | 1 |
| Sorà, F | 1 |
| Sica, S | 1 |
| De Stefano, V | 1 |
| Laurenti, L | 1 |
1 other study available for chlorambucil and Disseminated Intravascular Coagulation
| Article | Year |
|---|---|
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia.
Topics: Aged; Antibodies, Monoclonal, Humanized; Chlorambucil; Disseminated Intravascular Coagulation; Femal | 2021 |